SELLAS Life Sciences (SLS) Return on Equity Growth (1y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -3.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -1.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 0.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 2.00 |
| 10 | SELLAS Life Sciences | 1.61 Bn | 1.61 Bn | - | 1.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.00 |
| Dec 31, 2025 | 2.00 |
| Sep 30, 2025 | 3.00 |
| Jun 30, 2025 | 4.00 |
| Mar 31, 2025 | 40.00 |
| Dec 31, 2024 | -9.00 |
| Sep 30, 2024 | 73.00 |
| Jun 30, 2024 | -1.00 |
| Mar 31, 2024 | -38.00 |
| Dec 31, 2023 | 11.00 |
| Sep 30, 2023 | -74.00 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | -1.00 |
| Dec 31, 2022 | -4.00 |
| Sep 30, 2022 | -2.00 |
| Jun 30, 2022 | -3.00 |
| Mar 31, 2022 | -3.00 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 2.00 |
| Jun 30, 2021 | 1.00 |
| Mar 31, 2021 | 0.00 |
| Sep 30, 2018 | 0.00 |
| Jun 30, 2018 | 5.00 |
| Mar 31, 2018 | -24.00 |
| Dec 31, 2017 | -1.00 |
| Sep 30, 2017 | 0.00 |
| Jun 30, 2017 | 1.00 |
| Mar 31, 2017 | 344.00 |
| Dec 31, 2016 | 1.00 |
| Sep 30, 2016 | -1.00 |
| Jun 30, 2016 | -2.00 |
| Mar 31, 2016 | -346.00 |
| Dec 31, 2015 | -2.00 |
| Sep 30, 2015 | 1.00 |
| Jun 30, 2015 | 1.00 |
| Mar 31, 2015 | 0.00 |
| Dec 31, 2014 | 0.00 |
| Sep 30, 2014 | 0.00 |
| Jun 30, 2014 | 0.00 |
| Mar 31, 2014 | 0.00 |
| Dec 31, 2013 | -1.00 |
| Mar 31, 2013 | -32.00 |
| Dec 31, 2012 | 1.00 |